2018 American Transplant Congress
HOPE Act Deceased Organ Donors: True and False Positive Donors
1JHU, Baltimore; 2Mount Sinai, New York; 3Emory, Atlanta.
HOPE in Action is a multicenter trial designed to evaluate the safety of HIV+ to HIV+ transplantation (NCT02602262). In this trial, organs from donors with…2017 American Transplant Congress
Sexual Acquisition of HIV-Infection After Kidney Transplantation: Late Presentation and Potentially Fatal Complications.
Transplant Division, Hospital do Rim-UNIFESP, Sao Paulo, Brazil
Introduction: Transplantation in patients previously infected with HIV is already well established, and cases of donor infection transmission have already been reported. However late acquisition…2017 American Transplant Congress
HIV and Cognitive Impairment in Kidney Transplant Candidates.
Both HIV-infection and end stage renal disease (ESRD) are independently associated with neurocognitive decline. However, the combined impact of these diseases remains unclear, particularly among…2017 American Transplant Congress
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.
Renal transplantation is safe and effective in HIV patients with end stage renal disease (ESRD). High rates of acute rejection (AR) have been reported because…2017 American Transplant Congress
Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.
Introduction:HIV+ individuals can receive kidney transplant (KT) safely and effectively but face additional challenges from potential drug interactions between antiretroviral therapy (ART) and immunosuppression(IS). Little…2017 American Transplant Congress
Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.
Dermatology, Drexel, Philadelphia
Purpose: HIV and HCV are two immune dysregulatory processes that may exacerbate the risk of nonmelanoma skin cancer (NMSC) in organ transplant recipients (OTR), a…2017 American Transplant Congress
Emerging Variables Which May Enhance Care of HIV Positive Renal Transplant Recipients.
Transplantation, Mayo Clinic, Jacksonville, FL
Purpose: Single center experience of kidney and pancreas transplantation in the HIV positive populationMethods: Retrospective data and outcomes analysis of HIV positive kidney and pancreas…2017 American Transplant Congress
Willingness to Donate Organs Among Persons Living with HIV.
HIV-to-HIV organ transplants could shorten waitlist times among both HIV-infected (HIV+) and uninfected (HIV-) individuals. However, it is unknown whether HIV+ individuals are willing to…2017 American Transplant Congress
Immune Activation and Rejection Risk in HIV-Positive Kidney Transplantation.
Division of Transplantation, University of California, San Francisco, San Francisco, CA
Purpose: HIV+ kidney transplant recipients experience higher rates of rejection episodes when compared to HIV- recipients. We hypothesize that this early, aggressive rejection is associated…2017 American Transplant Congress
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants, including 7 ReTx. Herein we describe characteristics and allograft outcomes of HIV(+) kidney transplant recipients based on…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Next Page »